Mithra Pharmaceuticals

Belgium
Ligny, Wallonia, Belgium, 4000

Company profile

Mithra Pharmaceuticals company profile

Mithra Pharmaceuticals SA specializes in the development of women's health care products that are dedicated to the fields of contraception, fertility, and menopause. The two lead development candidates Estelle® (a fifth generation oral contraceptive) and Donesta® (a next generation hormone therapy) are built on Mithra's unique natural estrogen platform, E4 (Estetrol).

Business identity

Contact email
[email protected]
Phone number
+32 4 349 28 22
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Revenue range
$1M-$10M
Founded
1999-01-01, Year

Headquarters

Postal code
4000
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
6
Total equity funding
$72.4M
Last funding
Post IPO Debt / $21M / 2024-02-05
Last equity funding
Post IPO Equity / $21.6M
Investors
4
Lead investors
3
Founders
1
Articles
17
Exited on
2015-06-30

Founders and investors

Founders

François Fornieri

Lead investors

Armistice CapitalHighbridge Capital ManagementWhitebox Advisors

Investors

Armistice CapitalHighbridge Capital ManagementS.R.I.W.Whitebox Advisors